在加拿大儿科三级护理中心对药物耐药性的Cenobamate的初始经验
Alexander Freibauer1, Linda Huh1, Mary B Connolly1
1Department of Pediatrics, Division of Neurology, BC Children's Hospital, University of British Columbiahttps://ror.org/04n901w50, Vancouver, Canada.
概括
塞诺巴在70%的高度耐药性患者中有效降低了发作. 这种新型抗发作药物 (ASM) 具有良好的耐受性,在加拿大实践研究中由于不良影响而很少停止使用.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 塞诺巴是一种新型抗发作药物 (ASM),具有双重作用机制,向持久电流并调节GABA-A受体.
- 在2023年6月在加拿大获得批准,塞诺巴马特为管理提供了一种新的治疗选择.
研究的目的:
- 为了评估真实世界的有效性和耐受性cenobamate.
- 在市场推出后不久,评估Cenobamate在加拿大省综合性症计划中的实用性.
主要方法:
- 对2023年6月至2025年5月期间处方塞诺巴马特的患者进行了回顾性分析.
- 数据收集包括患者人口统计,病因,先前的治疗方法,赛诺巴剂量,疗效和不良事件.
主要成果:
- 该研究包括36名患有高度耐药性的患者 (平均年龄为18岁),其中许多患者之前的治疗失败 (平均10名ASM).
- 50%的患者实现了>50%的发作减少,20%的患者在平均10.5个月后实现了25%-50%的发作减少.
- 14%的患者没有发作;50%的患者经历了不良反应,但只有2人因副作用而停止服用药物,而没有人因为缺乏疗效而停止服用药物.
结论:
- 塞诺巴马特在现实环境中对具有高度耐药性的患者减轻发作频率表现出显著的有效性.
- 这种药物一般耐受性很好,因不良事件而停止使用的比例较低,支持其在这个具有挑战性的患者群体中使用.
相关概念视频
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...